NCT02233790 Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Status UNKNOWN Phase PHASE4
NCT02230241 CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II) Status COMPLETED Phase N/A
NCT02229656 Olaparib and Radiotherapy in Head and Neck Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02229396 Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Status COMPLETED Phase PHASE3
NCT02229383 Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02228369 Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT02227667 Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02227368 Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR Status TERMINATED Phase PHASE2
NCT02226822 DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan Status COMPLETED Phase N/A
NCT02226198 A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT02224157 A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma Status COMPLETED Phase PHASE3
NCT02224053 Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02223923 Phase I Study to Assess Safety of AZD6738 Alone and in Combination With Radiotherapy in Patients With Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02223065 Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State Status COMPLETED Phase PHASE1
NCT02216786 A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT02214654 A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage Status UNKNOWN Phase N/A
NCT02214121 A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT02211066 TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization Status COMPLETED Phase PHASE4
NCT02209766 A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids) Status COMPLETED Phase PHASE1
NCT02208921 An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes Patients Status COMPLETED Phase N/A